The Clorox Company : A long term support level to be taken advantage of
| Entry price | Target | Stop-loss | Potential |
|---|
|
US$119.83 |
US$131 |
US$113.8 |
+9.32% |
|---|
Clorox shares are sitting close to an important technical support area around 114.88 USD based on weekly price data. Against this backdrop, investors can use this good timing for new long positions.
Summary● The company has solid fundamentals for a short-term investment strategy.
● The share is getting closer to its long-term support in weekly data, at USD 114.88, which offers good timing for buyers.
● The close medium term support offers good timing for purchasing the stock.
● The group's activity appears highly profitable thanks to its outperforming net margins.
● There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
● With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
● The underlying tendency is negative on the weekly chart below the resistance at 133.11 USD
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.
THE CLOROX COMPANY 
